GLOBAL CHANNEL SALES
The Global Channel Sales (GCS) business is comprised of a network of more than 100 distributors, license partners, and wholesalers, through which we commercialise our products in more than 80 countries ensuring access to our essential medicines worldwide.
Europe is the heart of the GCS business, with commercial offices and manufacturing in both the UK and France. We have an established commercial channel across the continent via our numerous licensing partners, and a robust registration plan supporting multiple product launches in the coming months.
The Middle East and Africa are managed out of our office in Dubai. We have a Scientific office in Riyadh, providing an essential resource for registrations in Saudi Arabia. Through our network of partners, we cover all key markets in the Middle East, as well as Kenya, Nigeria, South Africa, Tanzania, and Uganda aiming to expand into North and Western Africa.
We have an office in Singapore, where our commercial and regulatory staff are based. This office is responsible for all the business in Asia, Australia, and New Zealand.
In North America, we have offices in Philadelphia and Montreal to support the growing list of license and distribution partners. Benefiting from FDA-approved manufacturing sites, we are steadily building a strong portfolio of products to support requirements in the US and Canada.